| Literature DB >> 34052101 |
Chen Chu1, Yan Geng1, Yu Zhou2, Piotr Sicinski3.
Abstract
E-type cyclins, collectively called cyclin E, represent key components of the core cell cycle machinery. In mammalian cells, two E-type cyclins, E1 and E2, activate cyclin-dependent kinase 2 (CDK2) and drive cell cycle progression by phosphorylating several cellular proteins. Abnormally elevated activity of cyclin E-CDK2 has been documented in many human tumor types. Moreover, cyclin E overexpression mediates resistance of tumor cells to various therapeutic agents. Recent work has revealed that the role of cyclin E extends well beyond cell proliferation and tumorigenesis, and it may regulate a diverse array of physiological and pathological processes. In this review, we discuss these various cyclin E functions and the potential for therapeutic targeting of cyclin E and cyclin E-CDK2 kinase.Entities:
Keywords: CDK2; cancer; cell cycle; cyclin E; cyclin-dependent kinases
Mesh:
Substances:
Year: 2021 PMID: 34052101 PMCID: PMC8364501 DOI: 10.1016/j.tcb.2021.05.001
Source DB: PubMed Journal: Trends Cell Biol ISSN: 0962-8924 Impact factor: 21.167